India to Australia: Imatinib Export Trade Route
India has recorded 11 verified shipments of Imatinib exported to Australia, representing a combined trade value of $1.4M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $128.4K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED , which accounts for 43% of total export value with 2 shipments worth $603.2K USD. On the buying side, SUN PHARMA ANZ PTY LTD., is the largest importer in Australia with $603.2K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED — together control 93% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Imatinib corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $1.4M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED , which alone accounts for roughly 43% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $128.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 34.5%, placing it at rank #1 among India's top imatinib export destinations globally.
On the import side, key buyers of Indian imatinib in Australia include SUN PHARMA ANZ PTY LTD., , SUN PHARMA ANZ PTY LTD., GENERIC HEALTH, and 2 others. SUN PHARMA ANZ PTY LTD., is the single largest importer with 2 shipments valued at $603.2K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#1
- Annual growth+34.5%
- Demand growth+29.5%
- Regulatory ease70/100
Top 10 Indian Imatinib Exporters to Australia
Showing top 10 of 5 Indian suppliers exporting Imatinib to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $301.6K per shipment | 2 | $603.2K | 42.7% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $69.5K per shipment | 6 | $416.9K | 29.5% |
| 3 | CIPLA LIMITED Avg $300.1K per shipment | 1 | $300.1K | 21.2% |
| 4 | DR REDDY S LABORATORIES LIMITED Avg $46.1K per shipment | 1 | $46.1K | 3.3% |
| 5 | DR REDDYS LABORATORIES LIMITED Avg $46.0K per shipment | 1 | $46.0K | 3.3% |
This table shows the top 10 of 5 Indian companies exporting imatinib to Australia, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 2 shipments worth $603.2K USD, giving it a 43% market share. The top 3 suppliers together account for 93% of the total trade value on this route.
Top 10 Imatinib Importers in Australia
Showing top 10 of 5 known buyers in Australia receiving Imatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian imatinib in Australia include SUN PHARMA ANZ PTY LTD., , SUN PHARMA ANZ PTY LTD., GENERIC HEALTH,, XX RXXDYSXXABOXXTORXXS (XXSTRXXIA)XXTY XXD, Dr Reddy s Laboratories Australia Pty LIMITED. The largest importer is SUN PHARMA ANZ PTY LTD., , accounting for $603.2K USD across 2 shipments — representing 43% of all imatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMA ANZ PTY LTD., | 2 | $603.2K | 42.7% |
| 2 | SUN PHARMA ANZ PTY LTD. | 6 | $416.9K | 29.5% |
| 3 | GENERIC HEALTH, | 1 | $300.1K | 21.2% |
| 4 | XX RXXDYSXXABOXXTORXXS (XXSTRXXIA)XXTY XXD | 1 | $46.1K | 3.3% |
| 5 | Dr Reddy s Laboratories Australia Pty LIMITED | 1 | $46.0K | 3.3% |
Top 10 Imatinib Formulations Imported by Australia
Showing top 10 of 9 product formulations shipped on the India to Australia Imatinib route, ranked by trade value
Australia imports a wide range of imatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — IMATINIB MESYLATE TABLETS 400MG (IMATINI — accounts for $379.4K USD across 2 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IMATINIB MESYLATE TABLETS 400MG (IMATINI | 2 | $379.4K | 26.9% |
| 2 | IMATINIB GH 400 MG CAPSULES (INV. QTY.3825 PACK 3X10S=114750 NOS) | 1 | $300.1K | 21.2% |
| 3 | IMATINIB MESYLATE TABLETS 100MG (IMATINI | 1 | $278.5K | 19.7% |
| 4 | IMATINIB MESYLATE TAB 400MG(IMATINIB RBXTAB 400 MG):PACK:Box3x10s,Batch:PTF5235B MFD : 12.11.2024 EXP : 31.10.2027 | 1 | $133.8K | 9.5% |
| 5 | IMATINIB DRLA 400MGCAPS 30S AUSTRALIA | 2 | $92.2K | 6.5% |
| 6 | IMATINIB MESYLATE TABLETS 400MG (IMATINIB RBX TAB 400 MG) EACH FILM COATED TABLETS CONTAINS: IMATINIB MESILATE EQUIVALEN | 1 | $90.8K | 6.4% |
| 7 | IMATINIB MESYLATE TABLETS 100MG BATCH :PTF5236B MFD : 07.11.2024 EXP : 31.10.2027 | 1 | $59.6K | 4.2% |
| 8 | IMATINIB MESYLATE TABS 400MG(IMANIB TAB400MG)EACH FILM COATED TABS CONT. IMATINIB MESILATE EQ.TO IMATINIB PH.EUR 400MG* | 1 | $47.6K | 3.4% |
| 9 | IMATINIB MESYLATE TABS 100MG(IMANIB TAB100MG)EACH FILM COATED TABS CONT. IMATINIB MESILATE EQ.TO IMATINIB PH.EUR 100MG* | 1 | $30.5K | 2.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 5 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's imatinib exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED — together account for 93% of total trade value on this route. The average shipment value of $128.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as imatinib gh 400 mg capsules (inv. qty.3825 pack 3x10s=114750 nos) and imatinib mesylate tablets 100mg (imatini , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMA ANZ PTY LTD., is the largest importer with 2 shipments worth $603.2K USD — representing 43% of all imatinib imports from India on this route.
Route Statistics
- Trade Volume
- $1.4M
- Avg. Shipment
- $128.4K
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~34 days
- Annual Growth
- +34.5%
Reverse Direction
Australia → India — Imatinib (Import)Other Imatinib Routes
Unlock the Full India to Australia Imatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Australia Imatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Imatinib to Australia?
The leading Indian exporters of Imatinib to Australia are SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 43% of total trade value on this route.
Q What is the total value of Imatinib exports from India to Australia?
India exports Imatinib to Australia worth approximately $1.4M USD across 11 recorded shipments. The average value per shipment is $128.4K USD.
Q Which ports does India use to ship Imatinib to Australia?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 5 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Australia for Imatinib?
The average transit time for Imatinib shipments from India to Australia is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Imatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 34.5% with demand growth tracking at 29.5%. The route is ranked #1 among India's top Imatinib export destinations globally.
Q How many suppliers are active on the India to Australia Imatinib route?
There are currently 5 active Indian suppliers exporting Imatinib to Australia. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 43% of total shipment value.
Q Who are the main importers of Imatinib from India in Australia?
The leading importers of Indian Imatinib in Australia include SUN PHARMA ANZ PTY LTD., , SUN PHARMA ANZ PTY LTD., GENERIC HEALTH,, XX RXXDYSXXABOXXTORXXS (XXSTRXXIA)XXTY XXD, Dr Reddy s Laboratories Australia Pty LIMITED. SUN PHARMA ANZ PTY LTD., is the largest buyer with 2 shipments worth $603.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Imatinib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists